SCOPE Europe 2022

April 20-21, 2022 | Barcelona, Spain

We are thrilled to announce that this year we will be joining the 4th Annual Summit for Clinical Trials Operations Executives Europe (SCOPE Europe). SCOPE Europe is a two-day hybrid event serving clinical innovation leaders, clin ops execs, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. 

This year, we will attend as delegate and speakers. Alessandro Monterosso, Director, Digital Health Solutions of Alira Health, will be joining a panel discussion “Reimagining Clinical Trials: The Digital Transformation in Catalonia” moderated by Montse Daban, Director, Scientific and International Relations of Biocat.  

Published on:
April 12, 2022
Our panelist:
Alessandro Monterosso

Alessandro Monterosso

Director, Digital Health Solutions, Alira Health Alessandro started his professional career as a Clinical Research Nurse, conducting studies first in Pediatrics and after graduating in applied Research, in Oncology. He co-authored several research papers and a handbook on clinical nursing procedures. In 2018, Alessandro worked at Ferring pharmaceuticals, leading Patient centricity programs in women’s health. In 2018, he graduated from SDA Bocconi in International Healthcare Management, Economics, and Policy, and in 2020, he graduated in Leadership and Innovation at the Massachusetts Institute of Technology.
Our delegate:
Camille Vinçon

Camille Vinçon

Business Development Director

Related news

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.